about
DNA Sequence Modulates the Conformation of the Food Mutagen 2-Amino-3-methylimidazo[4,5- f ]quinoline in the Recognition Sequence of the Nar I Restriction Enzyme † , ‡Base-displaced intercalation of the 2-amino-3-methylimidazo[4,5-f]quinolone N2-dG adduct in the NarI DNA recognition sequenceBase-displaced intercalated structure of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in the recognition sequence of the NarI restriction enzyme, a hotspot for -2 bp deletions.Translesion synthesis past the C8- and N2-deoxyguanosine adducts of the dietary mutagen 2-Amino-3-methylimidazo[4,5-f]quinoline in the NarI recognition sequence by prokaryotic DNA polymerasesBase-Displaced Intercalated Conformation of the 2-Amino-3-methylimidazo[4,5-f]quinoline N(2)-dG DNA Adduct Positioned at the Nonreiterated G(1) in the NarI Restriction Site.Screening reactive metabolites bioactivated by multiple enzyme pathways using a multiplexed microfluidic system.DNA polymerases κ and ζ cooperatively perform mutagenic translesion synthesis of the C8-2'-deoxyguanosine adduct of the dietary mutagen IQ in human cellsActivation of aminoimidazole carcinogens by nitrosation: mutagenicity and nucleotide adducts.DNA adduct formation by 7H-dibenzo[c,g]carbazole and its tissue- and organ-specific derivatives in Chinese hamster V79 cell lines stably expressing cytochrome P450 enzymes.Translesion Synthesis of the N(2)-2'-Deoxyguanosine Adduct of the Dietary Mutagen IQ in Human Cells: Error-Free Replication by DNA Polymerase κ and Mutagenic Bypass by DNA Polymerases η, ζ, and Rev1.Characterization of the 4-(benzothiazol-2-yl)phenylnitrenium ion from a putative metabolite of a model antitumor drugSynthesis of C8-arylamine-modified 2'-deoxyadenosine phosphoramidites and their site-specific incorporation into oligonucleotides.
P2860
Q27646503-95AF94DB-6CE0-4B0D-9577-64C704A20187Q27681071-17A6A162-8CA3-4982-9E7F-3DD37725A5BDQ33252465-BAD8DA38-83BB-4346-901E-987919BEAE31Q35148064-593B394F-6C28-4A61-90C4-914CFFF37ADFQ35879285-76A039D1-002A-467E-A00E-1AFFE871F950Q36431430-89DB9835-E672-4EC2-8D91-E3A9CDC26867Q36676696-6D5105A5-4310-41B8-A13B-F6D13B1B69DBQ37417186-2E2E4809-E710-4057-BA8F-48AE605379F3Q40494075-CEC8D66B-D04A-401D-9CCE-66D343DA4C83Q41142464-107FC9D7-6EC5-49C5-9A82-B27765FC2EA7Q42010715-9A429373-A88B-4FB2-B421-D31356034E4FQ54526327-338B0B54-7176-4EE2-B38E-51AC77F0BC96
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
N-hydroxyarylamines.
@ast
N-hydroxyarylamines.
@en
N-hydroxyarylamines.
@nl
type
label
N-hydroxyarylamines.
@ast
N-hydroxyarylamines.
@en
N-hydroxyarylamines.
@nl
prefLabel
N-hydroxyarylamines.
@ast
N-hydroxyarylamines.
@en
N-hydroxyarylamines.
@nl
P2860
P356
P1476
N-hydroxyarylamines.
@en
P2093
F Peter Guengerich
P2860
P304
P356
10.1081/DMR-120005663
P407
P577
2002-08-01T00:00:00Z